Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

First Edition

Research Article September 18 2024
Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma
Amrita Y. Krishnan,Krina K. Patel,Meera Mohan,Sundar Jagannath,Ruben Niesvizky,Rebecca W. Silbermann,Ziji Yu,Tao Long,Scott R.P. McDonnell,Deborah Berg,Keith E. Stockerl-Goldstein
View article
Supplementary data
Research Article September 16 2024
Lenalidomide, Ixazomib or Daratumumab Maintenance Therapy in Multiple Myeloma
Eunice Lai,Yu Yang Soon,Ainsley Ryan Yan Bin Lee,Shi Yin Wong,Cinnie Yentia Soekojo,Melissa Ooi,Wee Joo Chng,Sanjay de Mel
View article
Supplementary data
Research Article September 16 2024
Diagnostic Genomic Analysis is Prognostic in AYA ALL Patients Treated on a MRD-Stratified Pediatric Protocol
DT Yeung,LN Eadie,J Rehn,SL Heatley,BJ McClure,EC Page,CE Schutz,MP Osborn,T Trahair,R Sutton,MJ Henderson,J Kwan,S Mapp,L Dalla-Pozza,K Bradstock,M Greenwood,DL. White
View article
Supplementary data
Research Article September 5 2024
BIRC5 Upregulation Enhances DNMT3A-Mutant T-ALL Cell Survival and Pathogenesis
Wangisa M.B. Dunuwille,W. Casey Wilson,Hassan Bjeije,Nancy Issa,Wentao Han,Tyler M. Parsons,Andrew L. Young,Infencia Xavier Raj,Aishwarya Krishnan,Tarang Gaur,Eunice S. Wang,Andrew P. Weng,Matthew C. Stubbs,Hamza Celik,Amanda F. Cashen,John R. Edwards,Grant A. Challen
View article
Supplementary data
Research Article August 28 2024
COVID-19 vaccination in patients with classic and variant hairy cell leukemia
Robert J. Kreitman,Lacey James,Julie Feurtado,Holly Eager,Olena Sierra Ortiz,Mory Gould,Isaac Shpilman,Hong Zhou,Peter D. Burbelo,Jeffrey I. Cohen,Hao-Wei Wang,Constance M. Yuan,Evgeny Arons
View article
Research Article August 28 2024
Targeting SLFN11-Regulated Pathways Restores Chemotherapy Sensitivity in AML
Sara H. Small,Ricardo E. Perez,Elspeth M. Beauchamp,Aneta H. Baran,Stephen D. Willis,Mariafausta Fischietti,Michael Schieber,Masha Kocherginsky,Diana Saleiro,Leonidas C. Platanias
View article
Supplementary data
Research Article August 28 2024
Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia
Kuo-Kai Chin,Yannis Valtis,Andriy Derkach,Meira Yisraeli Salman,Leora Boussi,Jenna Ciervo,Mark B. Geyer,Jae H. Park,Martin S. Tallman,Jacob L. Glass,Aaron D. Goldberg,Eytan M. Stein
View article
Supplementary data
Brief Report August 28 2024
A phase 1 study of adding pitavastatin to venetoclax-based therapy in AML and CLL/SLL: a tolerable, mechanism-based, drug repurposing strategy
Elizabeth A Brem,Kevin Shieh,Dennis Juarez,Roberta Buono,Deepa Jeyakumar,Susan O’Brien,Thomas H Taylor,David A Fruman
View article
Supplementary data
Research Article July 31 2024
CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas
Paola Ghione,Kurt S. Bantilan,Erel Joffe,M Lia Palomba,Ariela Noy,Philip Caron,Paul Hamlin,Anita Kumar,Matthew Matasar,Colette Owens,Alison Moskowitz,Lorenzo Falchi,David Straus,Steven Horwitz,Gilles Salles,Ahmet Dogan,Andrew D. Zelenetz
View article

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 

Advertisement intended for health care professionals

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals